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Interactions between selective factors (hypertension and tuberculosis) and environmental effects (vitamin D deﬁciency [VDD], temperature,
and altitude) largely explain cystic ﬁbrosis (CF) carrier geography. For VDD sequelae such as hypertension and tuberculosis vulnerability, clinical
evidence of carrier protection is supported by indications that decreased CF arylsulfatase B activity suppresses tuberculosis, and that excess CF salt
loss decreases blood pressure. A need for salt retention in the tropics selected against CF carriers despite possible advantages against cholera, typhoid,
and other factors, but salt retention was less important elsewhere. Increased hypertension with cold selected for carriers with increasing latitude, and
with altitude, where hypertensive complications of pregnancy also rise.ΔF508 rates especially seem to follow these parameters, andmay be particularly
protective against hypertension, while lower rates in Ashkenazi Jews are consistent with a greater role for tuberculosis in this group. This scenario
suggests geographical correlations of CF with other genes affecting blood pressure, and signiﬁcant carrier levels, especially ofΔF508, in mountainous
areas of Asia with VDD.
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: cystic ﬁbrosis; heterozygotic advantage; vitamin D deﬁciency; tuberculosis; hypertension; delta F508; altitude; temperature.CF carrier rates of 4% ormore despite traditional homozygotic
lethality suggest heterozygotic advantages, with relatively high,
intermediate, and low to negligible frequencies in different areas
supporting differences in selection. A variety of mechanisms
have been proposed [1-3], and resistance to tuberculosis seems
well supported [1]. However, evidence exists for more complex
interactions of vitamin D deficiency (VDD) with tuberculosis
and hypertension, and altitude and temperature with hypertension
alone.
Overall, a role for VDD has two lines of support:
First, CF heterozygosity generally correlates with past areas
of VDD, one of the great selective pressures on Caucasians [4].
Relative frequencies are low in Eskimos, where diet was ade-
quate; elsewhere, skin production from ultraviolet light, whose
intensity is inversely related to latitude, is generally crucial,⁎ Tel.: +1 414 702 9579.
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where light skin, which increases ultraviolet absorption, reflects
VDD related selection. Skin exposure, influenced by tempera-
ture, season, and cultural factors, also has an effect, with interme-
diate carrier rates in Moslem areas with VDD secondary to
culturally decreased exposure [4, 5].
Second, while CFTR doesn't seem to directly affect vitamin
D metabolism [6], mutations can mitigate at least two deficiency
sequelae: Tuberculosis susceptibility and hypertension.
Clinical findings of tuberculosis vulnerability with VDD are
supported by laboratory evidence of a role for vitamin D in sup-
pressing and killing mycobacteria [6, 7]. At the same time,
clinical observations of tubercular protection in CF homo- and
hetero- zygotes are supported by indications that decreased CFs
arylsulfatase B activity reduces sulfate availability for mycobac-
terial cell wall synthesis [8].
With this, European CF heterozygosity has been epidemio-
logically linked to a tuberculosis pandemic from the early 17thby Elsevier B.V. All rights reserved.
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a role here: Cold, a major VDD risk factor, was the worst in the
millennium in the 17th century, and climate change devastated
fisheries for cod, a good source of vitamin D [9], possibly
exacerbating deficiencies.
However, high carrier rates with altitude (Table 1) despite
decreased tuberculosis [10], and intermediate heterozygosity
without past pandemics, as in the Middle East [11], suggest
additional factors. Hypertension is a good candidate: VDD in-
creases blood pressure [12] and interacting obstetrical prob-
lems [13], while systemic blood pressure decreases with CF,
possibly from increased sweat sodium loss [14], and carriers,
especially women, had lower blood pressure [15]. Less inher-
ited hypertension in whites than blacks [16, 17] is also consis-
tent with selection against high blood pressure in areas of past
VDD.
A possible exception to a VDD/carrier correlation is high
heterozygosity with altitude despite greater ultraviolet light,
although other factors can still lead to VDD here [18]. However,
hypertensive complications of pregnancy rise with altitude [19],
and cold increases blood pressure [20], maintaining significant
selection in such areas even without any contribution from VDD.
ΔF508, the most common CF allele [2], may be especially
selected for here, following cooler temperatures with an in-
creasing Southeast to Northwest European frequency [2, 21],
as well as altitude (Table 1, and possibly Baluchistan [3]).
Supporting a link to hypertension, other salt regulating genes
also correlate with latitude, and with altitude, as with Basques
[22, 23]. Contrariwise, relatively low ΔF508 rates in Ashkenazi
Jews [2] are consistent with a greater role for selection against
tuberculosis in this group [24].
Together, these factors help explain most of the geography
of CF carriers:
1. Protection from tropical factors such as typhoid fever can
favor certain metabolically neutral CFTR polymorphisms
[25, 26]. However, heterozygous CF alleles can cause salt
losses [27], and, even when similarly protective, were elim-
inated in these areas by a need for retention in the face of
heat losses [15].Table 1
Prevalence of CF and Δf508 Carriers at High Altitudes⁎ and Adjacent Areas.
Area ΔF508% ΔF508 carriers per 1000
people (calculated)
CF prevalence
(Births for 1 case)
Austria (total) [2, 28] 62.9 10.6 3500
⁎Austria (Tyrol) [2] 74.6
⁎Switzerland [2] 57.2 12.8 2000








Spain [2, 24] 52.7 8.6 3750
Note: Comparisons are complicated by a decreasing Northwest-Southeast frequency
gradient [2].2. Outside of the tropics, VDD from decreased light selected
for greater Vitamin D production and for amelioration of
VDD effects, while selection for salt retention was relaxed
or reversed [15].
3. Hypertension associated with VDD and with salt retention in
non-tropical areas selected for CF and other mitigating genes
affecting sodium metabolism.
4. Worsening of VDD and hypertension with cold resulted in a
CF temperature/latitude gradient.
5. While VDD could decrease with altitude, blood pressure
remained an important selective force at high elevations be-
cause of greater hypertensive mortality with cold and/or
altitude.
6. VDD related susceptibility to tuberculosis helped define the
scope and timing of a European pandemic that began in the
17th century.
7. Tuberculosis subsequently selected for CF carrier protection
in that same area.
8. Different CF alleles may have different protective effects:
ΔF508 associates with areas of hypertensive risk, while
others are more linked to tuberculosis. Alleles effective
against typhoid, cholera, and other factors [26] may also
have had a role in certain non-tropical areas.
This scenario suggests geographical correlations of CF with
other, especially salt related, genes affecting hypertension, and
significant carrier levels, especially for ΔF508, in mountainous
areas of Asia with VDD [18]. Better world-wide statistics are
needed, correlated with estimates of historic VDD.
References
[1] Poolman EM, Galvani AP. Evaluating candidate agents of selective pressure
for cystic fibrosis. J R Soc Interface 2007;4:91–8.
[2] Bobadilla JL, Macek Jr M, Fine JP, Farrell PM. Cystic Fibrosis: A world-
wide analysis of CFTR mutations -Correlation with incidence data and
application to screening. Hum Mutat 2002;19:575–606.
[3] Saleheen D, Frossard PM. The cradle of the delta F508 mutation. J Ayub
Med Coll Abbottabad 2008;20:157–60.
[4] Bereket A. Rickets in Developing Countries. In: Hochberg Z, editor. Karger,
Basel, Vitamin D and Rickets, 6. Endocr Dev.; 2003. p. 220–32.
[5] Baroncelli GI, Bereket A, El Kholy M, et al. Rickets in the Middle East:
Role of environment and genetic predisposition. J Clin Endocrinol Metab
2008;93:1743–50.
[6] Yim S, Dhawan P, Ragunath C, Christakos S, DiamondG. Induction of cathe-
licidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin
D(3). J Cyst Fibros 2007;6:403–10.
[7] Nuoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a
systematic review and meta-analysis. Int J Epidemiol 2008;37:113–9.
[8] Tobacman JK. Does deficiency of arylsulfatase B have a role in cystic
fibrosis? Chest 2003;123:2130–9.
[9] Pope PE. Fish into Wine: The Newfoundland Plantation in the Seventeenth
Century. Chapel Hill, NC: University of North Carolina Press; 2004.
p. 33–4.
[10] Saito M, Pan WK, Gilman RH, et al. Comparison of altitude effect on
Mycobacterium tuberculosis infection between rural and urban commu-
nities in Peru. Am J Trop Med Hyg 2006;75:49–54.
[11] DawsonKP.Cystic Fibrosis in Children of the Eastern Arabian Peninsula. A
Clinical, Spatial and Genetic Study. Thesis for the Degree of Doctor of
Health Sciences, Deakin University. http://tux.lib.deakin.edu.au/adt-VDU/
uploads/approved/adt-VDU20050728.091141/public/01front.pdf
70 M. Lubinsky / Journal of Cystic Fibrosis 11 (2012) 68–70[12] Forman JP, Curhan GC, Taylor EN. Plasma 25-Hydroxyvitamin D levels
and risk of incident hypertension among young women. Hypertens
2008;52:828–32.
[13] Bodnar LM, Catov JM, Simhan HN, Holick MF, Powers RW, Roberts
JM. Maternal vitamin D deficiency increases the risk of preeclampsia. J
Clin Endocrinol Metab 2007;92:3517–22.
[14] Lieberman J, Rodbard S. Low blood pressure in young adults with cystic
fibrosis. An effect of chronic salt loss in sweat? Ann Intern Med 1975;82:
806–8.
[15] Super M, Irtiza-Ali A, Roberts SA, et al. Blood pressure and the cystic
fibrosis gene. Evidence for lower pressure rises with age in female carriers.
Hypertens 2004;44:878–83.
[16] Weder AB. Evolution and Hypertension. Hypertens 2007;49:260–5.
[17] Bochud M, Staessen JA, Maillard M, et al. Ethnic differences in proximal
and distal tubular sodium reabsorption are heritable in black and white
populations. J Hypertens 2009;27:606–12.
[18] Norsang G, Ma L, Dahlback A, et al. The vitamin D status among Tibetans.
Photochem Photobiol 2009;85:1028–31.
[19] Zamudio S, Plamer SK, Regensteiner JG, Moore LG. High altitude and
hypertension during pregnancy. Am J Hum Biol 1995;7:183–93.
[20] Ulmer H, Kelleher C, Diem G, Concin H, Ruttmann E. Estimation of
seasonal variations in risk factor profiles and mortality from coronary
heart disease. Wien Klin Wochenschr 2004;116:662–8.[21] Peel MC, Finlayson BL, McMahon TA. Updated world map of the Köppen-
Geiger climate classification. Hydrol Earth Syst Sci 2007;11:1633–44.
[22] Thompson EE, Kuttab-Boulos H, Witonsky D, Yang L, Roe BA, Di Rienzo
A. CYP3A variation and the evolution of salt-sensitivity variants. Am J Hum
Genet 2004;75:1059–69.
[23] Casals T, Vázquez C, Lázaro C, Girbau E, Giménez FJ, Estivill X. Cystic
fibrosis in the Basque country: high frequency of mutation delta F508 in
patients of Basque origin. Am J Hum Genet 1992;50:404–10.
[24] Diamond J. Curse and Blessing of the Ghetto. Discover 1991;12:60–6.
[25] Kuningas M, van Bodegom D, May L, Meij JJ, Slagboom PE, Westendorp
RGJ. Common CFTR gene variants influence body composition and
survival in rural Ghana. Hum Genet 2010;127:201–6.
[26] van de Vosse E, de Visser AW, Al-Attar S, Vossen R, Ali S, van Dissel
JT. Distribution of CFTR variations in an Indonesian enteric fever cohort.
Clin Infect Dis 2010;50:1231–7.
[27] Farrell PM, Koscik RE. Sweat chloride concentrations in infants homozygous
or heterozygous for F508 cystic fibrosis. Pediatr 1996;97:524–8.
[28] Farrell P. The prevalence of cystic fibrosis in the European Union. J Cyst
Fibros 2008;7:450–3.
[29] Festini F, Taccetti G, Repetto T, et al. Incidence of cystic fibrosis in the
Albanian population. Pediatr Pulmonol 2008;43:1124–9.
